药品名称TRAVASOL 4.25% SULFITE FREE W/ ELECTROLYTES IN DEXTROSE 20% IN PLASTIC CONTAINER
申请号020147产品号009
活性成分AMINO ACIDS; DEXTROSE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC; SODIUM ACETATE; SODIUM CHLORIDE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格4.25%;20GM/100ML;51MG/100ML;261MG/100ML;297MG/100ML;77MG/100ML
治疗等效代码参比药物
批准日期1995/10/23申请机构BAXTER HEALTHCARE CORP
化学类型New formulation or new manufacturer审评分类Standard review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
020147006APLetter2000/04/12下载
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
020147009AP2001/08/14Manufacturing Change or Addition
020147008AP2000/03/24Control Supplement
020147007AP1999/11/24Manufacturing Change or Addition
020147006AP2000/04/12Efficacy Supplement with Clinical Data to Support
020147004AP1999/03/31Control Supplement
020147003AP1997/11/06Manufacturing Change or Addition
020147002AP1997/10/09Labeling Revision
020147001AP1997/04/29Package Change
020147000AP1995/10/23Approval